|
Katherine Dailey, Anavi Prakash, Zara Norman, Jessie Nguyen and Zhiyu Solstice Luo, Medill Investigative Lab; and Debbie Cenziper, ProPublica
The calls came over the span of a single month in 2004, patient after patient with strikingly similar complaints. Some told Oregon psychiatrist James Hancey that their new generic medication for depression had stopped working. Others described unexpected reactions — dizziness, flu-like symptoms and electric shock sensations in the brain.
“That started to tell me, ‘This drug is no good,’” Hancey said. “You get all these phone calls where people are saying the exact same thing.”
Hancey suspected that the generic was ineffective, and that his patients were suffering from abrupt withdrawal. But he had no easy way to confirm exactly where the pills came from or the safety record of the factory that made them.
Read More
|